Elevated serum levels of soluble axl in acute coronary syndrome

American Journal of the Medical Sciences

Volumn 349, Issue 2, 2015, Pages 124-129

  Liu, Yu Wei ^a   Yang, Qun Fang ^a   Zuo, Pei Yuan ^a   Xiao, Chang Liang ^a   Chen, Xing Lin ^a   Liu, Cheng Yun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute coronary syndrome; Atherosclerosis; Coronary heart disease; Inflammation; Soluble Axl

Indexed keywords

AXL PROTEIN; C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URIC ACID; AXL RECEPTOR TYROSINE KINASE; BIOLOGICAL MARKER; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIAC PATIENT; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; URIC ACID BLOOD LEVEL; AGED; BLOOD; CLINICAL TRIAL; METABOLISM; MIDDLE AGED;

ACUTE CORONARY SYNDROME; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; TROPONIN I;

EID: 84923689409     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0000000000000362     Document Type: Article

References (29)

1. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/ World Health Organization task force on standardization of clinical nomenclature. Circulation 1979;59:607-9
2. Falk E, Nakano M, Bentzon JF, et al. Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013;34:719-28
3. Matusik P, Guzik B, Weber C, et al. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?. Thromb Haemost 2012;108:443-56
4. Hafizi S, Dahlback B. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 2006;273: 5231-44
5. Budagian V, Bulanova E, Orinska Z, et al. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Mol Cell Biol 2005;25:9324-39
6. Mullberg J, Rauch CT, Wolfson MF, et al. Further evidence for a common mechanism for shedding of cell surface proteins. FEBS Lett 1997;401:235-8
7. O'Donnell K, Harkes IC, Dougherty L, et al. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am J Pathol 1999;154: 1171-80
8. Melaragno MG, Wuthrich DA, Poppa V, et al. Increased expression of Axl tyrosine kinase after vascular injury and regulation by G proteincoupled receptor agonists in rats. Circ Res 1998;83:697-704
9. D'Arcangelo D, Gaetano C, Capogrossi MC. Acidification prevents endothelial cell apoptosis by Axl activation. Circ Res 2002;91:e4-12
10. Melaragno MG, Cavet ME, Yan C, et al. Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt. J Mol Cell Cardiol 2004;37:881-7
11. Fridell YW, Villa JJ, Attar EC, et al. GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J Biol Chem 1998;273: 7123-6
12. Angelillo-Scherrer A, Burnier L, Flores N, et al. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest 2005;115:237-46
13. Angelillo-Scherrer A, de Frutos P, Aparicio C, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001;7:215-21
14. Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001;293: 306-11
15. Tjwa M, Moons L, Lutgens E. Pleiotropic role of growth arrestspecific gene 6 in atherosclerosis. Curr Opin Lipidol 2009;20:386-92
16. Maree AO, Jneid H, Palacios IF, et al. Growth arrest specific gene (GAS) 6 modulates platelet thrombus formation and vascular wall homeostasis and represents an attractive drug target. Curr Pharm Des 2007;13:2656-61
17. Jiang L, Liu CY, Yang QF, et al. Plasma level of growth arrestspecific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome. Am J Clin Pathol 2009;131: 738-43
18. Ekman C, Stenhoff J, Dahlback B. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost 2010; 8:838-44
19. Balogh I, Hafizi S, Stenhoff J, et al. Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol 2005;25:1280-6
20. Korshunov VA, Mohan AM, Georger MA, et al. Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res 2006;98:1446-52
21. Korshunov VA, Daul M, Massett MP, et al. Axl mediates vascular remodeling induced by deoxycorticosterone acetate-salt hypertension. Hypertension 2007;50:1057-62
22. Stanton LW, Garrard LJ, Damm D, et al. Altered patterns of gene expression in response to myocardial infarction. Circ Res 2000;86:939-45
23. Satoh M, Ishikawa Y, Itoh T, et al. The expression of TNF-alpha converting enzyme at the site of ruptured plaques in patients with acute myocardial infarction. Eur J Clin Invest 2008;38:97-105
24. Bamberg F, Truong QA, Koenig W, et al. Differential associations between blood biomarkers of inflammation, oxidation, and lipid metabolism with varying forms of coronary atherosclerotic plaque as quantified by coronary CT angiography. Int J Cardiovasc Imaging 2012;28: 183-92
25. Otake H, Shite J, Shinke T, et al. Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome. Am J Cardiol 2008;101:1-7
26. Hurtado B, Munoz X, Recarte-Pelz P, et al. Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques. Thromb Haemost 2011;105:873-82
27. Zoller B, Garcia DFP, Dahlback B. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995;85:3524-31
28. Lee CH, Shieh YS, Hsiao FC, et al. High glucose induces human endothelial dysfunction through an Axl-dependent mechanism. Cardiovasc Diabetol 2014;13:53
29. Kim YS, Jung DH, Sohn E, et al. Glycoxidised LDL induced the upregulation of Axl receptor tyrosine kinase and its ligand in mouse mesangial cells. PLoS One 2012;7:e50297